Tempus AI is positioned for growth as US pharmaceutical reshoring and regulatory scrutiny increase demand for data-driven healthcare services. Click for my TEM stock update.
Tempus AI: Expansive Opportunity As Healthcare Becomes More Heavily Scrutinized (TEM)

128